BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 29, 2026
Home
»
Topics
»
Drugs
» Immuno-oncology
Immuno-oncology
RSS
Biomira suspends two cancer vaccine programs to focus on advanced products
Dec. 3, 2001
Boehringer Ingelheim and ImmunoGen to develop new TAP product
Nov. 30, 2001
Orphan drug status granted for IL-13-PE38 for the treatment of malignant glioma
Nov. 28, 2001
Phase II trial of GVAX cancer vaccine for acute myelogenous leukemia set to commence
Nov. 28, 2001
Cell Genesys and Japan Tobacco modify cancer vaccines agreement
Nov. 27, 2001
Early phase I data for CEA/TRICOM encouraging
Nov. 23, 2001
Virulizin enters phase III for treatment of pancreatic cancer
Nov. 22, 2001
PI-88 may have use in the treatment of leukemia
Nov. 21, 2001
Ethics committee approval granted for PI-88 phase II trial in multiple myeloma
Nov. 14, 2001
New phase II trial of Mylovenge in conjunction with thalidomide
Nov. 12, 2001
Previous
1
2
…
917
918
919
920
921
922
923
924
925
…
1002
1003
Next
RSS